OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.
May 13, 2022
Promising 2-year data for the IL-17 targeting biologic were recently presented at AAD 2022.
May 06, 2022
Exact triggers in acute urticaria and chronic urticaria are largely unknown, with the success of identifying causes of AU varying between 21-68%.
Previous research has suggested that psoriasis could affect both fecundity and fertility, leading to spontaneous abortion and ectopic pregnancy.
May 05, 2022
The current registered dosing of the therapy is 30 mg twice daily, but the analyzed dosage of 20 mg has not yet been approved.
Similarly, patients affected by alopecia areata had higher odds of developing psoriasis.
May 04, 2022
New 5-year data shows psoriasis improvement was similar among patients with and without metabolic syndrome, regardless of which dose they received.
April 28, 2022
Dr. McKinley-Grant details the new health movement that aims to stop the cycle of suffering for people of color living with psoriatic disease.
April 27, 2022
However, comorbidity risk was believed to be substantially different between the two diseases.
April 16, 2022
Elapsed time following diagnosis, naïve biologic therapy status and previous use of only 1 biologic were associated with higher persistence rates.
April 13, 2022
New 108 week data found that treatment with the biologic resulted in significant skin clearance in pediatric patients with psoriasis.